Italian Real-Life Experience on the Use of Mogamulizumab in Patients with Cutaneous T-Cell Lymphomas
Laura Caruso,1 Alessia Castellino,2 Daniela Dessì,3 Leonardo Flenghi,4 Antonio Giordano,5 Adalberto Ibatici,6 Cesare Massone,7 Alessandro Pileri,8 Ilaria Proietti,9 Livio Pupo,10 Pietro Quaglino,11 Serena Rupoli,12 Pier Luigi Zinzani13,14 1Hematology and Bone Marrow Transplantation Unit, Azienda Osp...
Main Authors: | Caruso L, Castellino A, Dessì D, Flenghi L, Giordano A, Ibatici A, Massone C, Pileri A, Proietti I, Pupo L, Quaglino P, Rupoli S, Zinzani PL |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2022-11-01
|
Series: | Cancer Management and Research |
Subjects: | |
Online Access: | https://www.dovepress.com/italian-real-life-experience-on-the-use-of-mogamulizumab-in-patients-w-peer-reviewed-fulltext-article-CMAR |
Similar Items
-
Impact of Mogamulizumab in Real-Life Advanced Cutaneous T-Cell Lymphomas: A Multicentric Retrospective Cohort Study
by: Marie Jouandet, et al.
Published: (2022-03-01) -
Mogamulizumab Combined with Extracorporeal Photopheresis as a Novel Therapy in Erythrodermic Cutaneous T-cell Lymphoma
by: Nadia Ninosu, et al.
Published: (2023-12-01) -
Quality of Life in Cutaneous T-cell Lymphoma Patients Receiving Mogamulizumab: Important Factors to Consider
by: Rosanne Ottevanger, et al.
Published: (2022-12-01) -
Cost–utility analysis of mogamulizumab in advanced mycosis fungoides and Sezary syndrome cutaneous T-cell lymphoma
by: Noemi Muszbek, et al.
Published: (2023-06-01) -
Overall survival in the UK in mycosis fungoides or S ´ ezary syndrome cutaneous T-cell lymphoma: comparative effectiveness of mogamulizumab versus current standard of care
by: Neil Hawkins, et al.
Published: (2023-08-01)